ABSTRACT
INTRODUCTION
Atherosclerosis, the primary cause of ischemic cardiomyopathy and ultimately a major contributing factor to death, is strongly correlated with hypertension, hyperlipidemia and type II diabetes mellitus. Urotensin II (UII) is the most potent vasoactive peptide identified to date with a potency that overcomes other vasoactive agents like endothelin-1 (ET-1), angiotensin II, serotonin and thromboxane A2
(1) . UII is cyclic peptide of 11 amino acids sharing structural similarity to somatostatin and binds to a class of G-protein coupled receptor known as GPR14 or recently named urotensin receptor (UT) (2) . UII/UT complex has been found to be elevated in vascular endothelial dysfunction-related diseases such as essential hypertension, atherosclerosis, coronary artery disease and congestive heart failure (3) . UII is highly expressed in endothelial cells, monocytes, macrophage-derived foam cells, myointima and vascular smooth muscle cells (VSMCs) of atherosclerotic human coronary artery using immunohistochemistry, in situ hybridization and reverse transcriptase-polymerase chain reaction (RT-PCR) (4) .
Palosuran (ACT-058362; 1-[2-(4 benzyl-4-hydroxy-pepridin-1-yL)-ethyl]-3-(2-methyl-ginolin-4-yl)-urea sulfate salt) is a non peptidic competitive UT receptor antagonist that binds to two populations of UII binding sites. To date, palosuran is the first UT receptor antagonist that has been tested in human (5) . The aim of the present work is to study the role of chronic exogenously administered UII in the pathogenesis of atherosclerosis in high cholesterol fed rats and the effect of blocking endogenously expressed UII by palosuran.
MATERIAL & METHODS
This study was carried out on 32 male wistar rats, collected randomly weighing 200 + 50gm body weight. These animals were housed under 12 hours day/night cycle at room temperature. They were classified into 2 groups. I-Control group (8 Table ( 1), Fig. (1) show that LDL-C, TG and total cholesterol significantly increased after high cholesterol diet while HDL-C significantly decreased when compared to normal control group (P <0.05).
RESULTS
UII group showed significant increase in LDL-C, TG and total cholesterol and significant decrease of HDL-C when compared to either high cholesterol diet or UII groups (P <0.05).
Palosuran group led to significant decrease of LDL-C, TG and total cholesterol and significant increase in HDL-C when compared to high cholesterol diet rats (P <0.05).
As shown in 
DISCUSSION
The results of the present study suggest a prominent role of UII in mediating atherosclerosis in high cholesterol fed rats as evidenced from hyperlipidemia (increased LDL-C, TG and total Ch. and decreased HDL-C), inflammatory and atherosclerotic markers ( 
